医学
肿瘤浸润淋巴细胞
乳腺癌
肿瘤科
预测值
内科学
佐剂
生物标志物
疾病
辅助治疗
临床试验
免疫系统
癌症
免疫疗法
免疫学
化学
生物化学
作者
Carmen Criscitiello,Angela Esposito,Dario Trapani,Giuseppe Curigliano
标识
DOI:10.1016/j.ctrv.2016.09.019
摘要
It is well recognized that the immune system plays an essential role in tumor defense. The presence of tumor-infiltrating lymphocytes reflects an individual immunological response. In early breast cancer, the presence of TILs is associated with a more favorable outcome and response to therapy. In this review, we describe how TILs are assessed. Also, we discuss their role as prognostic and predictive biomarker in the neoadjuvant and adjuvant settings as well as in residual disease. Moreover, we discuss the possible implementation of TILs in daily clinical practice as well as in future clinical trials in order to fine tune prognosis and improve treatments.
科研通智能强力驱动
Strongly Powered by AbleSci AI